Giant Biogene Holding Co., Ltd.
2367
Rang in aandelen
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Aandeelprijs
$2.67
Marktkapitalisatie
$2.84B
Verandering (1 dag)
-6.09%
Verandering (1 jaar)
-46.20%
Land
CN
Handel Giant Biogene Holding Co., Ltd. (2367)
Categorie
Consumer Defensive
P/B-ratio voor Giant Biogene Holding Co., Ltd. (2367)
P/B-ratio op October 2026 TTM: 2.00
Volgens de meest recente financiële rapporten en aandelenkoers van Giant Biogene Holding Co., Ltd. is de huidige P/B-ratio (TTM) 2.00. Eind 2024 had het bedrijf een P/B-ratio van 6.60.
P/B-ratiohistoriek voor Giant Biogene Holding Co., Ltd. van 2019 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 2.00 | -37.21% |
| 2025 | 3.19 | -51.68% |
| 2024 | 6.60 | -9.00% |
| 2023 | 7.25 | -29.02% |
| 2022 | 10.22 | -50.98% |
| 2021 | 20.85 | -57.14% |
| 2020 | 48.63 | 136.00% |
| 2019 | 20.61 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 6.9837 | 248.68% |
US
|
|
| 6.3772 | 218.40% |
FR
|
|
| 315.2455 | 15,639.45% |
US
|
|
| 8.7627 | 337.50% |
IN
|
|
| 9.8894 | 393.75% |
US
|
